|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
47,410,000 |
Market
Cap: |
990.39(M) |
Last
Volume: |
961,860 |
Avg
Vol: |
367,276 |
52
Week Range: |
$22.22 - $57.73 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Health Services |
Level
III Sector: |
Medical Instruments & Supplies |
|
Member Indexes:
|
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile AtriCure provides treatments for atrial fibrillation (Afib), left atrial appendage management and post-operative pain. Co.'s ablation and left atrial appendage management products are used by physicians during both open-heart and minimally invasive procedures. Co.'s Isolator® Synergy Ablation System is approved by U.S. Food and Drug Administration (FDA) for the treatment of persistent and long-standing persistent Afib concomitant to other open-heart surgical procedures. The EPi-Sense® system is approved by FDA to treat patients with long-standing persistent Afib. All of Co.'s other ablation devices are cleared for sale in U.S., including its other radio frequency and cryoablation products.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
13,116 |
13,116 |
22,981 |
35,584 |
Total Sell Value |
$468,797 |
$468,797 |
$967,781 |
$1,531,699 |
Total People Sold |
2 |
2 |
4 |
6 |
Total Sell Transactions |
4 |
4 |
8 |
11 |
End Date |
2024-02-04 |
2023-11-03 |
2023-05-05 |
2022-05-05 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Carrel Michael H |
President, CEO, & Director |
|
2023-03-01 |
4 |
GD |
$0.00 |
$0 |
D/D |
1,600 |
597,053 |
|
- |
|
Carrel Michael H |
President, CEO, & Director |
|
2023-03-01 |
4 |
D |
$38.81 |
$1,764,691 |
D/D |
(45,470) |
598,653 |
|
- |
|
Carrel Michael H |
President, CEO, & Director |
|
2023-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
115,227 |
644,123 |
|
- |
|
Yount Deborah Lee |
Chief Human Resources Officer |
|
2023-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
12,239 |
29,433 |
|
- |
|
Doraiswamy Vinayak |
Chief Scientific Officer |
|
2023-03-01 |
4 |
D |
$38.81 |
$186,016 |
D/D |
(4,793) |
38,753 |
|
- |
|
Doraiswamy Vinayak |
Chief Scientific Officer |
|
2023-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
24,140 |
43,546 |
|
- |
|
Dahlquist Karl S. |
Chief Legal Officer |
|
2023-03-01 |
4 |
D |
$38.81 |
$267,556 |
D/D |
(6,894) |
40,736 |
|
- |
|
Dahlquist Karl S. |
Chief Legal Officer |
|
2023-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
24,140 |
47,630 |
|
- |
|
Seith Douglas J |
Chief Operating Officer |
|
2023-03-01 |
4 |
D |
$38.81 |
$453,572 |
D/D |
(11,687) |
110,455 |
|
- |
|
Seith Douglas J |
Chief Operating Officer |
|
2023-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
42,507 |
122,142 |
|
- |
|
Wirick Angela L |
Chief Financial Officer |
|
2023-03-01 |
4 |
D |
$38.81 |
$137,077 |
D/D |
(3,532) |
91,792 |
|
- |
|
Wirick Angela L |
Chief Financial Officer |
|
2023-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
24,478 |
95,324 |
|
- |
|
White Robert S. |
Director |
|
2023-02-27 |
4 |
OE |
$8.48 |
$169,600 |
D/D |
20,000 |
75,799 |
|
- |
|
Seith Douglas J |
Chief Operating Officer |
|
2022-12-30 |
4 |
A |
$34.86 |
$21,230 |
D/D |
609 |
79,635 |
|
- |
|
Noznesky Justin J |
Chief Mktg & Strategy Officer |
|
2022-12-30 |
4 |
A |
$34.86 |
$20,393 |
D/D |
585 |
38,414 |
|
- |
|
Yount Deborah Lee |
Chief Human Resources Officer |
|
2022-12-30 |
4 |
A |
$34.86 |
$10,249 |
D/D |
294 |
17,194 |
|
- |
|
Carrel Michael H |
President, CEO, & Director |
|
2022-11-17 |
4 |
GD |
$0.00 |
$0 |
D/D |
6,000 |
528,896 |
|
- |
|
Doraiswamy Vinayak |
Chief Scientific Officer |
|
2022-09-15 |
4 |
S |
$45.99 |
$229,168 |
D/D |
(4,983) |
19,406 |
|
6% |
|
White Robert S. |
Director |
|
2022-08-31 |
4 |
OE |
$8.48 |
$127,200 |
D/D |
15,000 |
55,799 |
|
- |
|
Wirick Angela L |
Chief Financial Officer |
|
2022-08-06 |
4 |
D |
$50.94 |
$264,430 |
D/D |
(5,191) |
70,846 |
|
- |
|
Dahlquist Karl S. |
Chief Legal Officer |
|
2022-06-30 |
4 |
A |
$34.73 |
$12,156 |
D/D |
350 |
23,490 |
|
- |
|
Doraiswamy Vinayak |
Chief Scientific Officer |
|
2022-06-30 |
4 |
A |
$34.73 |
$12,156 |
D/D |
350 |
24,389 |
|
- |
|
Carrel Michael H |
President, CEO, & Director |
|
2022-06-30 |
4 |
A |
$34.73 |
$12,156 |
D/D |
350 |
534,896 |
|
- |
|
Privitera Salvatore |
Chief Technical Officer |
|
2022-06-30 |
4 |
A |
$34.73 |
$12,156 |
D/D |
350 |
60,834 |
|
- |
|
Yount Deborah Lee |
Chief Human Resources Officer |
|
2022-06-01 |
4 |
A |
$0.00 |
$0 |
D/D |
16,900 |
16,900 |
|
- |
|
531 Records found
|
|
Page 3 of 22 |
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Acquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|